Investment
Features
FeesSafety
Academy
More
Pluang+

BrandPilot AI to present on AI-driven ad budget efficiency in upcoming webinar

Market News
29 Sep 2026
Newsfile Corp
View Source
Neutral
BrandPilot AI to present on AI-driven ad budget efficiency in upcoming webinar

BrandPilot AI announced it will participate in a webinar hosted by Search Engine Land on October 1, 2026, focusing on how AI can uncover inefficiencies and optimize digital advertising budgets. The webinar will feature BrandPilot's Chief Growth Officer and discuss the role of AI in improving advertising performance and budget allocation. This event aligns with BrandPilot's mission to enhance transparency and efficiency in digital advertising through AI technology. The company does not expect this participation to materially impact its financials but sees it as part of ongoing industry engagement and education.

BrandPilot AI's upcoming webinar on AI-powered advertising efficiency is the subject here. For readers following the Technology sector, here is Pluang's market snapshot as of Sep 30, 2026 03:02 WIB: Of 150 priced Technology-sector US stocks tradable on Pluang, 63 rose and 87 fell today. Notable movers include NTES at USD 120.95 (+4.80%), GLW at USD 158.77 (+4.80%), and PANW at USD 392.21 (+4.66%).

More News

Micron projects record $51.33B revenue driven by AI memory demand, with EPS soaring to $31.72 this quarter.

Micron projects record $51.33B revenue driven by AI memory demand, with EPS soaring to $31.72 this quarter.

Micron Technology is set to report record quarterly revenue of up to $51.33 billion, fueled by strong demand for high-bandwidth memory in the AI market. Earnings per share are expected to jump significantly to around $31.72, compared to $3.03 last ye...

Company Fundamentals
Bullish
1 hour ago
Sangoma beats EPS estimates but misses revenue; acquisition deal boosts shares 35%.

Sangoma beats EPS estimates but misses revenue; acquisition deal boosts shares 35%.

Sangoma Technologies reported a smaller-than-expected loss with an EPS of -$0.08, beating analyst estimates of -$2.19, though its revenue of $48.55 million slightly missed expectations. Despite ongoing profitability challenges reflected in a negative...

Company Fundamentals
Bullish
3 hours ago
Iovance Biotherapeutics raises 2026 revenue forecast with strong Q2 sales and analyst optimism.

Iovance Biotherapeutics raises 2026 revenue forecast with strong Q2 sales and analyst optimism.

Iovance Biotherapeutics has increased its full-year 2026 revenue guidance to $410-$420 million, reflecting nearly 60% growth driven by strong U.S. demand for its cancer therapy Amtagvi, which generated $91 million in Q2 sales. Analyst Joseph Pantgini...

Analyst Insights
Bullish
4 hours ago
uniQure shares drop 37% after mixed results in Huntington's gene therapy trial

uniQure shares drop 37% after mixed results in Huntington's gene therapy trial

uniQure's stock fell sharply by 37% following a four-year update on its AMT-130 gene therapy for Huntington's disease, which showed reduced effectiveness from 80% at three years to 44% at four years, failing to reach statistical significance. Despite...

Market News
Bearish
4 hours ago
Altrova Health settles C$215K debt by issuing shares, preserving cash and reducing liabilities.

Altrova Health settles C$215K debt by issuing shares, preserving cash and reducing liabilities.

Altrova Health Inc. has settled C$215,000 of outstanding debt by issuing 3,583,333 common shares at a price of C$0.06 per share to three creditors. This debt settlement did not bring in cash but helped reduce the company's liabilities and preserve ca...

Company Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App